Evidence map›Paper›PMID 33288540›Full record

ReviewCold Spring Harbor perspectives in biology2021

Influenza-Specific Lung-Resident Memory CD8

Stephanie van de Wall, Vladimer P Badovinac, John T Harty

Open access · bronzeAbstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 23 citations in OpenAlex.

  1. Monocyte-derived galectin-1Nature immunology · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Inverted HA-EV immunization elicits stalk-specific influenza immunity and cross-protection in mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  11. Article
  12. Review
  13. Fighting flu: novel CD8Clinical & translational immunology · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Influenza-Induced CD103ImmunoHorizons · 2022
    Article
  19. Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Stephanie van de WallDepartment of Microbiology and Immunology, University of Iowa, Iowa City, Iowa 52242, USA.
Vladimer P BadovinacDepartment of Microbiology and Immunology, University of Iowa, Iowa City, Iowa 52242, USA.
John T HartyDepartment of Microbiology and Immunology, University of Iowa, Iowa City, Iowa 52242, USA.
University of Iowa · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the availability of seasonal vaccines, influenza A (IAV) prevails as a leading cause of respiratory infection worldwide. Current vaccination efforts aim at increasing protection against heterologous and potentially pandemic IAV strains. Lung-resident CD8

Indexed as

CD8-Positive T-LymphocytesMemory T CellsAnimalsHumansInfluenza, HumanInfluenza VaccinesLungInfluenza Vaccines

Identifiers

PMID33288540
PMCPMC7849341
OpenAlexW3113219464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.